Doximity, Inc. (NASDAQ:DOCS) Holdings Lowered by Aigen Investment Management LP

Aigen Investment Management LP decreased its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 24.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,800 shares of the company's stock after selling 4,677 shares during the quarter. Aigen Investment Management LP's holdings in Doximity were worth $790,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of DOCS. FMR LLC increased its position in shares of Doximity by 30.5% in the third quarter. FMR LLC now owns 6,837,733 shares of the company's stock valued at $297,920,000 after buying an additional 1,598,602 shares in the last quarter. State Street Corp boosted its stake in Doximity by 2.5% in the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company's stock worth $160,947,000 after buying an additional 88,922 shares during the last quarter. Geode Capital Management LLC boosted its stake in Doximity by 19.8% in the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company's stock worth $124,503,000 after buying an additional 472,565 shares during the last quarter. Los Angeles Capital Management LLC boosted its stake in Doximity by 33.7% in the 4th quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company's stock worth $46,466,000 after buying an additional 219,448 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Doximity by 3.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 778,524 shares of the company's stock worth $41,565,000 after buying an additional 25,523 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Remove Ads

Doximity Stock Down 2.8 %

DOCS stock traded down $1.87 during trading on Friday, reaching $64.09. 1,919,244 shares of the company's stock were exchanged, compared to its average volume of 2,433,665. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $85.21. The company's fifty day moving average price is $62.80 and its 200-day moving average price is $51.82. The firm has a market cap of $11.96 billion, a PE ratio of 64.09, a P/E/G ratio of 4.10 and a beta of 1.34.

Insiders Place Their Bets

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the business's stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 37.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

DOCS has been the topic of a number of research analyst reports. Morgan Stanley raised Doximity from an "underweight" rating to an "equal weight" rating and raised their price target for the stock from $33.00 to $53.00 in a research note on Thursday, November 14th. Leerink Partnrs raised Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Piper Sandler upgraded Doximity from a "neutral" rating to an "overweight" rating and raised their target price for the company from $31.00 to $78.00 in a report on Friday, February 7th. Needham & Company LLC raised their target price on Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a report on Friday, February 7th. Finally, Canaccord Genuity Group downgraded Doximity from a "buy" rating to a "hold" rating and raised their target price for the company from $40.00 to $60.00 in a report on Wednesday, November 13th. Eleven analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $64.22.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.